Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02972580 · ClinicalTrials.gov registry record
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
A clinical trial of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy, sponsored by Nationwide Children's Hospital.
- Active
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT02972580: Active study of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy, sponsored by Nationwide Children's Hospital.
NCT02972580 is a study of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy that is active but no longer recruiting, run by Nationwide Children's Hospital. The registered enrollment target is 250 participants, below the 407-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02972580, a study of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy, is active but no longer recruiting, sponsored by Nationwide Children's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
Longitudinal prospective observational study. This is a 24-month study with the possibility of extending the data time points. Initially baseline, then 12 and 24 months follow up studies will be completed.
Primary Outcome
Cardiac function as compromised by evidence of scarring of cardiac muscles, particularly of the base of the left ventricle via cardiac MRI studies with gadolinium contrast.
Conditions Studied
Interventions
- GENETIC Genetic characterization
Study Locations (1)
Ohio
- Nationwide Children's Hosptial - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2016-06 |
| Est. Completion | 2030-12 |
What the registry record for NCT02972580 still lists
NCT02972580 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 407-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (39% lower).
The record links to 2 conditions, with Duchenne Muscular Dystrophy appearing as the primary indexed condition, and to 1 intervention - of which Genetic characterization is the first listed.
NCT02972580 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02972580 about?
NCT02972580 is a clinical study titled "Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD". Longitudinal prospective observational study. This is a 24-month study with the possibility of extending the data time points. Initially baseline, then 12 and 24 months follow up studies will be completed.
What is the current status of trial NCT02972580?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2016-06. Estimated completion is 2030-12.
What conditions does trial NCT02972580 study?
This clinical trial studies the following conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy.
What interventions are being tested in trial NCT02972580?
The interventions under investigation include: Genetic characterization (GENETIC).
Who is sponsoring clinical trial NCT02972580?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02972580 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Duchenne Muscular Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02972580's enrollment target sits among peer trials
250 6th of 48 higher than 42 of 48 other Duchenne Muscular Dystrophy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Duchenne Muscular Dystrophy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
RECRUITING · Phase 1
-
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
RECRUITING · Phase 2
-
Once Weekly Infant Corticosteroid Trial for DMD
RECRUITING · Phase 4
-
The Duchenne Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia